151533-33-4

Basic information

• Product Name: 4-hydroxy-4-methyl-2-(4'-[2''-piperidino]ethoxy)phenyl-3-(4'''-tetrahydropyranyloxy)phenyl-7-tetrahydropyranyloxychromane
• Synonyms: 4-hydroxy-4-methyl-2-(4'-[2''-piperidino]ethoxy)phenyl-3-(4'''-tetrahydropyranyloxy)phenyl-7-tetrahydropyranyloxychromane
• CAS NO: 151533-33-4
• Molecular Weight: 643.821
• Mol File: 151533-33-4.mol

Chemical Properties

• CAS DataBase Reference: 4-hydroxy-4-methyl-2-(4'-[2''-piperidino]ethoxy)phenyl-3-(4'''-tetrahydropyranyloxy)phenyl-7-tetrahydropyranyloxychromane(CAS DataBase Reference)
• NIST Chemistry Reference: 4-hydroxy-4-methyl-2-(4'-[2''-piperidino]ethoxy)phenyl-3-(4'''-tetrahydropyranyloxy)phenyl-7-tetrahydropyranyloxychromane(151533-33-4)
• EPA Substance Registry System: 4-hydroxy-4-methyl-2-(4'-[2''-piperidino]ethoxy)phenyl-3-(4'''-tetrahydropyranyloxy)phenyl-7-tetrahydropyranyloxychromane(151533-33-4)

Safety Data

• Hazardous Substances Data: 151533-33-4(Hazardous Substances Data)

Upstream product

• 252353-08-5 chalcone 
• 110-87-2 3,4-dihydro-2H-pyran 
• 156-38-7 4-hydroxyphenylacetate 
• 108-46-3 recorcinol 
• 676-58-4 methylmagnesium chloride 
• 151533-32-3 2-(4''-[2'''-piperidinoethoxy]phenyl)-3-(4'-tetrahydropyranyloxyphenyl)-7-tetrahydropyranyloxy-2,3-dihydro-4H-1-benzopyran-4-one 
• 130064-21-0 1-(2-hydroxy-4-((tetrahydro-2H-pyran-2-yl)oxy)phenyl)-2-(4-((tetrahydro-2H-pyran-2-yl)oxy)phenyl)ethanone 
• 17720-60-4 2,4,4'-trihydroxy deoxybenzoin 

Downstream Products

• 182167-59-5 (2S)-7-hydroxy-3-(4'-hydroxyphenyl)-4-methyl-2-((4''-[2'''-piperidino]ethoxy)phenyl)-2H-1-benzopyran (1S)-10-camphorsulphonic acid salt 
• 252353-10-9 (2R,S)-7-hydroxy-3-(4'-hydroxyphenyl)-4-methyl-2-(4-[2'-piperidino]ethoxy)phenyl-2H-1-benzopyran (1S)-10-camphorsulphonic acid salt 
• 182167-04-0 EM-800 
• 182167-04-0 EM-776 
• 182167-02-8 Acolbifene 
• 151533-34-5 2-[4-[2-(1-piperidino)ethoxy]phenyl]-3-(4-hydroxyphenyl)-4-methyl-7-hydroxy-2H-1-benzopyran 

Relevant articles and documents

TREATMENT OF HOT FLUSHES, VASOMOTOR SYMPTOMS, AND NIGHT SWEATS WITH SEX STEROID PRECURSORS IN COMBINATION WITH SELECTIVE ESTROGEN RECEPTOR MODULATORS

Novel methods for reduction or elimination of the incidence of hot flushes, vasomotor symptoms, and night sweats while decreasing the risk of acquiring breast, uterine or endometrial cancer and furthermore having beneficial effect by inhibiting the develo

TREATMENT OF MALE ANDROGEN DEFICIENCY SYMPTOMS OR DISEASES WITH SEX STEROID PRECURSOR COMBINED WITH SERM

Novel methods for prevention, reduction or elimination of the incidence of male androgen deficiency symptoms or diseases including male hypogonadism-associated symptoms and diseases associated with low serum testosterone and/or low DHEA or low total andro

Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors

Novel methods for the medical treatment and/or inhibition of the development of osteoporosis, breast cancer, hypercholesterolemia, hyperlipidemia or atherosclerosis in susceptible warm-blooded animals including humans involving administration of selective